The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 25680029 |
12 |
Discovery of potent, orally bioavailable, small-molecule inhibitors of WNT signaling from a cell-based pathway screen. |
The Institute of Cancer Research |
| 24786387 |
58 |
Synthesis and biological evaluation of a unique heparin mimetic hexasaccharide for structure-activity relationship studies. |
Momenta Pharmaceuticals |
| 23844574 |
71 |
Identification of NVP-TNKS656: the use of structure-efficiency relationships to generate a highly potent, selective, and orally active tankyrase inhibitor. |
Novartis Institutes For Biomedical Research |
| 2825043 |
23 |
8-Cyclopentyl-1,3-dipropylxanthine (DPCPX)--a selective high affinity antagonist radioligand for A1 adenosine receptors. |
UniversitÄT Heidelberg |
| 17149865 |
28 |
Subtle side-chain modifications of the hop phytoestrogen 8-prenylnaringenin result in distinct agonist/antagonist activity profiles for estrogen receptors alpha and beta. |
Ghent University |
| 9753691 |
10 |
Structural basis of inhibitor selectivity in MAP kinases. |
University of Texas At Dallas |
| 15149678 |
32 |
1,7-annulated indolocarbazoles as cyclin-dependent kinase inhibitors. |
Eli Lilly |
Search and Browse
